[Problems found in the isolation of mycelial fungi (Fusarium solani) from blood culture (Bacter NR-860)].
BACKGROUND
F. solani fungemia is unusual. Patients at risk are immunosuppressed, have underlying malignancy or severe debilitating diseases.


METHODS
We report two cases of F. solani fungemia in two non neutropenic patients who had been treated with wide-spectrum antibiotics an/or systemic corticosteroids, parenteral nutrition and intravenous lines. Bactec NR-860 (Becton-Dickinson) system was used, and growth was detected in aerobic conditions (between 3-7 days of incubation).


RESULTS
Removal of the catheters with or without i.v. amphotericin B were used successfully.


CONCLUSIONS
The spectrum of Fusarium sp. fungemia is discussed. Current available antifungal therapy is also reviewed.
Sanz
F
F
Public Health Laboratory, Micological Reference Laboratory, Londres, Reino Unido.
Soledad Cuétara
M
M
del Palacio
A
A
Campbell
C K
CK
Johnson
L
L
Urruzunu
P
P
Pía Roiz
M
M
D000368:Aged; D001431:Bacteriological Techniques; D001769:Blood / Q000382:microbiology*; D002675:Child, Preschool; D005260:Female; D005670:Fusarium / Q000302:isolation & purification*; D006801:Humans; D008297:Male
Problemas que plantea el aislamiento en hemocultivo (Bactec NR-860) de hongos miceliales (Fusarium solani).